Attached files

file filename
EX-32 - EX-32 - Celldex Therapeutics, Inc.a2231216zex-32.htm
EX-31.2 - EX-31.2 - Celldex Therapeutics, Inc.a2231216zex-31_2.htm
EX-31.1 - EX-31.1 - Celldex Therapeutics, Inc.a2231216zex-31_1.htm
EX-23.1 - EX-23.1 - Celldex Therapeutics, Inc.a2231216zex-23_1.htm
10-K - 10-K - Celldex Therapeutics, Inc.a2231216z10-k.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 21.1

SUBSIDIARIES OF CELLDEX THERAPEUTICS, INC.

Name
  Jurisdiction of
Organization
  Ownership
Percentage
 

Abigail Pharmaceuticals, Inc. 

  British Virgin Islands     100 %

Bulldog Pharmaceuticals, Inc. 

  British Virgin Islands     100 %

Celldex Australia PTY LTD

  Australia     100 %

Celldex Therapeutics Europe GmbH

  Switzerland     100 %

Eltam Pharmaceuticals, Inc. 

  British Virgin Islands     100 %



QuickLinks

SUBSIDIARIES OF CELLDEX THERAPEUTICS, INC.